CSA Medical Announces Completion of Enrollment in Mechanism of Action Study Utilizing the RejuvenAir^® System for COPD Patients with Chronic Bronchitis

CSA Medical, Inc. announced that all subjects have been enrolled in the RejuvenAir® System study. The aim of this study is to determine the mechanism by which Metered CryoSpray reduces the density of goblet cells responsible for over-producing mucus and observe re-growth of healthy cilia in the airways.